India: Online Pharmacies: Conundrum On Legality

Last Updated: 20 December 2018
Article by Rajesh Sivaswamy and Sindhuja Kashyap

Online Pharmacies: Conundrum on legality

"It is easy to get a thousand prescriptions, but hard to get one single remedy" so goes a popular Chinese proverb which succinctly summaries the pharmacy market in India and the debate surrounding e-pharmacies.

Overview of the legislative framework

In India, the sale of prescribed medications is controlled by the Drugs and Cosmetics Act, 1940 ("DCA"), Drugs and Cosmetics Rules, 1945, Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, Indian Medical Act, 1956 and Code of Ethics Regulations, 2002. Given the time that these laws were enacted, they are arguably silent on the issue of e-pharmacies and do not regulate direct online selling of professionally prescribed medications. Due to the advancement of technology, access of drugs through Internet is sought for by users and this corresponds directly to the numbers of internet users in India which has steadily been on the rise. It is estimated that there are over 3,500 sites dealing with online medicines across the country and given that e-pharmacies are largely unregulated there are concerns that the goods may be fake, expired, contaminated, unapproved and dangerous to patients and may put their health at risk. The Drugs and Cosmetics Act, 1940 does not distinguish between online and offline pharmacies.

On August 28, 2018, the Central Government vide notification vide its notification G.S.R. 817 (E) dated 28th August, 2018 proposed ePharmacy draft rules under Drugs and Cosmetics Act 1945 with an aim to regulate online sale of medicines across India and provide patients accessibility to genuine drugs from authentic online portals. Amongst others, the ePharmacy draft rules1 stated that no person will distribute or sell, stock, exhibit or offer for sale of drugs through e-pharmacy portal unless registered. Any person who intends to conduct business of e-pharmacy shall apply for the grant of registration to the Central Licensing Authority in Form 18AA through the online portal of the Central Government. The e-pharmacy draft rules contemplates that premises from where the e-pharmacy business is conducted shall be inspected, every two years, by a team of officers authorised by the Central Licensing Authority, with or without the experts in the relevant field or the officers authorised by the concerned State Licensing Authority. It has been proposed that those who want to do online pharmacy will have to register with the Central Drugs Standard Control Organization (CDSCO).

Present Situation

While the Government is yet to act and provide a legislation, most large online pharmacies are operating based on self-regulation2 and the industry as such has no standards to follow. The growth of online pharmacies has however had an impact on offline players' business and several bodies including the All India Organisation of Chemists and Druggists (AIOCD) and other similar trade bodies have voiced their opposition the unregulated growth of e-pharmacies. 

These frictions resulted in several litigations the first among which was dealt by the High Court of Judicature of Madras  in the case of N Ruthyramoorthy v Union of India & Ors4 and  The Tamil Nadu Chemists and Druggists Association vs Union of India & Ors4. In this case, a Writ petition was filed to direct the respondents to ban all such websites from selling Schedule-H, H1 and X medicines in violation of Rule 65 and 97 of Drugs & Cosmetics Rules, 1945 ("Rules") till the license were granted to sell medicines through the online medium and further recommend measures in order to ban all such websites.

The High Court of Madras, on December 20, 2016 stated in its order that a sub-committee has been constituted by the Drugs Consultative Committee ("DCC") to examine the issues relating to the sale of drugs over the internet and this report has been duly submitted to DCC. DCC has further submitted the report to Ministry of Health and Family Welfare for consideration. However, no further direction on stay or injunction on present sale of medicines was provided.

On August 28, 2018, Ministry of Health and Family Welfare ("Ministry"), in consonance to the report submitted by DCC, issued a draft on "Sale of Drugs by E-Pharmacy"5 for suggestions from public under Drugs and Cosmetic Amendment Rules, 2018 ("Rules 2018").

In absence of any interim measures available to curtail the sale of unregulated medicine through online medium, another case by the Tamil Nadu Chemists and Druggists Association vs Union of India & Ors6 was filed before the High Court of Judicature of Madras for obtaining interim relief in the matter.

Background of the Case

Petitioner had earlier approached the Court to block the link of all such websites from India who are selling Schedule H and Schedule X medicines in violation of Rule 65 and 97 of the Rules till the grant of licenses for online sale. However, the Court stated that new rules on the matter were being considered by the Ministry thereby providing no actionable directions on these websites. While a draft regulating online sale of medicine was welcomed, the Petitioner sought the leave of the Court seeking directions to block the link and sale of all such websites selling drugs online till legislation is enacted and the licenses are granted accordingly.

Issues at hand

  • Whether the sale of prescribed medicines through online platform without license is legal?
  • Whether online pharmacies are acting as intermediaries or pharmacy stores requiring license?


According to the learned senior counsel for the petitioner, online sellers are not following the procedure before selling drugs as per DCA. They are also selling the drugs included in Schedule H, H1 & X, which are only permitted to be sold with a valid prescription and under the supervision of a registered pharmacist, having licence. The learned senior counsel for the petitioner further submitted that subsequent to the order of this Court in W.P.No.28325 of 2016, the first respondent has issued the draft rules on 28.08.2018, legitimising the whole E-commerce sale of drugs. However, the Central Government has given 45 days' time to record and consider objections. While the matter is pending, online sale of the above mentioned drugs are still in existence without obtaining proper licences.

Delhi and Madras High Courts ban online sale of medicines

The Madras High Court, in view of the seriousness of the issue and public cause granted interim injunction against the online sale of medicines without licence and directed the first respondent or the competent authority to stall such online sales forthwith. Further, on December 17, 2018 the Madras High Court referred to the Rules 2018 and stated that "Though there is a statute, the regulatory rules are yet to be notified, in the wake of advancement of technology. Unless the legislation keeps pace with the technology, the commerce based on technology has to lag behind".

The Madras High Court in absence of notified draft Rules 2018 directed the online traders to not proceed with their online business in drugs and cosmetics unless the same is notified.

Further, the Madras High Court directed the Central and State Government to notify the proposed Rules 2018 at the earliest, no later than January 31, 2019 and the concerned stakeholders were directed to obtain licenses under the notified rules within two months from the date of notification in order to proceed with the online trade of drugs and cosmetics. However, an order was passed by the Madras High Court in furtherance of its judgement dated December 17, 2018 wherein Justice Pushpa Sathyanarayana had suspended the ban till 10:30 a.m. of December 20, 20187.

On December 20, 2018, following a request for extension of suspension Justice M Sathyanarayanan and P Rajamanickam passed an order stating that the order of suspension shall continue till the Court provides a final verdict in these miscellaneous petitions. The judgement seems to have been arrived on at after the contentions that there was no express law prohibiting such mode of business was brought in. The Madras High Court also clarified that the continuance of this order shall not create any equitable rights in favour of the appellants i.e the stakeholders.

It is pertinent to note that Madras High Court judgement seems to have arrived at this conclusion after the Delhi High Court Judgment in this regard. On December 12, 2018, a division bench of the Delhi High Court comprising of Chief Justice Rajendra Menon and Justice V Kameswar Rao in a PIL filed by Dr Zaheer Ahmed8 opined that there is no provision to sell drugs online and therefore, same shall be prohibited unless the draft Rules 2018 are notified by the Government. Further, on December 20, 2018 division bench of Delhi High Court extended the ban till January 08, 2019.


The above cases highlight several important issues and more importantly the lack of governance in public healthcare. We are highlighting key issues surrounding the legality of online pharmacies given the present legal and regulatory quagmire.

Present License Requirements

At the outset, section 189 of the DCA, restricts sale and exhibit or offer for sale of any drugs and cosmetics without obtaining license for the same. Therefore, it is crystal clear that the law permits sales of medicines only by a person who has obtained license under the DCA.

We have reviewed a number of online platform selling medicines and their business model can broadly be classified into two categories, first are those working as marketplace model wherein they obtain license under the DCA and store certain medicines for the purpose of sale and second are those working as intermediaries who merely function as a platform between the patient and the pharmacies.

While the former business model may not be a breach of existing legal regulations per se, the latter may have face legal challenges. The Rules 2018 states that no person shall distribute or sell, stock, exhibit or offer for sale of drugs through e-pharmacy portal unless registered.10 Therefore, the intention of the legislation is clear that irrespective of the online pharmacy acting as full-fledged pharmacy or intermediary, it is required to be registered.

There is also a valid concern that drugs included in Schedule H, H1 & X of the DCA which is permitted to be sold only with a valid prescription and under the supervision of a registered licensed pharmacist may be misused on an online platform and be ordered multiple times using the same prescription on a number of online portals. Adequate checks and balances should therefore be built into the draft Rules 2018.


On the basis of the existing legal regime and the pronouncements of the courts, we are of the view bearing in mind the seriousness of the issue and considering the effect on public health and safety, the judiciary has rightly stepped as a guardian of the larger public welfare. While we may see contrary opinion between the High Court of Madras and Delhi, the same seems to be a direct result of lack of legislation and delay in passing a new one. It is now upto the Government to expedite the legislation process and set in place a system that augurs well for all the stakeholders involved.




3 W.P. 5611/2016

4 W.P. 28325/2016

5 Notified in the Gazette of India bearing No. 602 dated August 28, 2018

6 W.P/28716/2018

7 W.P No. 28716/2018

8 W.P (C) No. 11711/2018

9 As per Section 18(c), no person shall himself or by any other person on his behalf manufacture for sale or for distribution, or sell, or stock or exhibit or offer for sale, or distribute any drug or cosmetic, except under, and in accordance with the conditions of, a licence issued for such purpose.

10 Section 67J of the Rules 2018.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of

To Use you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions